[RECOMMENDATION FOR EVALUATION AND TREATMENT OF CHRONIC URTICARIA - THE ISRAELI ASSOCIATION FOR ALLERGY AND CLINICAL IMMUNOLOGY].
Levin Agmon N(Sheba Medical Center), E Tobi(Bnai Zion Medical Center), Aharon Kessel(Technion – Israel Institute of Technology), Ronit Confino‐Cohen(Tel Aviv University), Tal Y(Hadassah Medical Center), Menachem Rottem(ENT and Allergy), Ramit Maoz‐Segal(Sheba Medical Center)
PubMed
June 1, 2017
Cited by 4
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients
|Allergy|2004|301
Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
|Autoimmunity Reviews|2011|293
Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function
|The Journal of Immunology|2007|229
Age-related autoimmunity
|BMC Medicine|2013|196